STARTUP PROFILE

CorTec

COUNTRY
Germany
FOUNDED
2010
CATEGORY
Brain-Computer Interface
Building a fully implantable, bidirectional neurostimulation and recording platform designed to restore neural function by sensing brain activity and delivering adaptive stimulation in closed loop.
Visit website →
Market Notes · Biweekly

Track this company

Funding, launches and regulatory moves across the neurotech startup map.

Subscribed. Check your inbox to confirm.

•
Neurofounders Insights
$   Funding   -
Unknown
MODALITY
ECoG
FORM FACTOR
Implant
INTERFACE DEPTH
Implantable
INDICATION
Rehabilitation
TARGET USER
Patients
REGULATORY STAGE
Investigational
CorTec is developing a fully implantable closed-loop neurostimulation platform, positioning itself as a next-generation alternative to traditional DBS systems with integrated sensing and adaptive stimulation. Its bidirectional architecture aligns with the broader shift toward closed-loop neuromodulation, though commercialization timelines remain unclear.
•
Mentioned in Market Notes
MOST RECENT COVERAGE
#
8
FDA Supports the BCI Mission
18 August – 1 September 2026

CorTec received its second FDA Breakthrough Device Designation for its Brain Interchange system, this one covering device control for people with non-progressive quadriplegia. The fully implantable device records neural activity and delivers adaptive stimulation in a closed loop. The same implant can now both aid motor recovery and let users control a computer using thoughts. The first designation, granted in April, covered stroke motor rehabilitation. CorTec is already running a stroke study at the University of Washington, where three participants received the implant, and one used it to control a computer.

Articles featuring
CorTec